Diabetic Macular Edema
Conditions
Interventions
Case series:None
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged >=18 years, no gender limit; 2. In patients with type 1 or type 2 diabetes, HbA1c value <=10%; 3. Diagnosed with CIDME; 4. The best corrected visual acuity is within 0.05-0.5 decimal visual acuity; 5. If both eyes met the inclusion criteria, the investigator decided to include a single eye; 6. Agreed to receive Compacept treatment after enrollment; 7. 12 months of follow-up is expected to be completed; 8. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating patients; 2. Intraocular surgery is expected within the next 6 months; 3. History of vitreoretinal surgery, cataract surgery, systemic anti-VEGF therapy and intraocular implant therapy within 6 months prior to treatment; 4. Intraocular anti-VEGF treatment history, ocular hormone use history and panretinal photocoagulation history within 3 months before treatment; 5. The target eye has uncontrollable glaucoma (intraocular pressure >=25mmHg after medical treatment) or a history of glaucoma filtration surgery; 6. Diagnosis or suspected intraocular/periocular infection and inflammation; 7. Serious systemic diseases (such as serious cardiovascular diseases, kidney diseases, etc.) and other eye diseases affect the judgment of the results; 8. Participating in other clinical trials/studies; 9. Other conditions that the researchers determined needed to be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| best corrected vision; | — |
Secondary
| Measure | Time frame |
|---|---|
| central subfield thickness;intraretinal fluid;subretinal fluid;cumulative number of injections;adverse event / reaction; | — |
Countries
China
Contacts
Public ContactXu Xun
Shanghai General Hospital
Outcome results
None listed